These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 26100920)
21. Biomarker Discovery in Parkinson's Disease: Present Challenges and Future Opportunities. Li S; Le W Neurosci Bull; 2017 Oct; 33(5):481-482. PubMed ID: 28936754 [No Abstract] [Full Text] [Related]
22. Human olfactory neurosphere-derived cells: A unified tool for neurological disease modelling and neurotherapeutic applications. Ansari S; Etekochay MO; Atanasov AG; Prasad VP; Kandimalla R; Mofatteh M; V P; Emran TB Int J Surg; 2024 Apr; ():. PubMed ID: 38652180 [TBL] [Abstract][Full Text] [Related]
23. α-Synuclein and Lewy pathology in Parkinson's disease. Kalia LV; Kalia SK Curr Opin Neurol; 2015 Aug; 28(4):375-81. PubMed ID: 26110807 [TBL] [Abstract][Full Text] [Related]
24. Low levels of astroglial markers in Parkinson's disease: relationship to α-synuclein accumulation. Tong J; Ang LC; Williams B; Furukawa Y; Fitzmaurice P; Guttman M; Boileau I; Hornykiewicz O; Kish SJ Neurobiol Dis; 2015 Oct; 82():243-253. PubMed ID: 26102022 [TBL] [Abstract][Full Text] [Related]
25. Distinctive distribution of phospho-alpha-synuclein in dermal nerves in multiple system atrophy. Doppler K; Weis J; Karl K; Ebert S; Ebentheuer J; Trenkwalder C; Klebe S; Volkmann J; Sommer C Mov Disord; 2015 Oct; 30(12):1688-92. PubMed ID: 26175301 [TBL] [Abstract][Full Text] [Related]
26. α-Synuclein in Parkinson's disease: getting to the core of the matter. Hauser RA Lancet Neurol; 2015 Aug; 14(8):785-786. PubMed ID: 26116313 [No Abstract] [Full Text] [Related]
27. Parkinson disease and progressive supranuclear palsy: protein expression in skin. Rodríguez-Leyva I; Chi-Ahumada EG; Carrizales J; Rodríguez-Violante M; Velázquez-Osuna S; Medina-Mier V; Martel-Gallegos MG; Zarazúa S; Enríquez-Macías L; Castro A; Calderón-Garcidueñas AL; Jiménez-Capdeville ME Ann Clin Transl Neurol; 2016 Mar; 3(3):191-9. PubMed ID: 27042679 [TBL] [Abstract][Full Text] [Related]
28. Alpha-synuclein immunoreactivity patterns in the enteric nervous system. Aldecoa I; Navarro-Otano J; Stefanova N; Sprenger FS; Seppi K; Poewe W; Cuatrecasas M; Valldeoriola F; Gelpi E; Tolosa E Neurosci Lett; 2015 Aug; 602():145-9. PubMed ID: 26163460 [TBL] [Abstract][Full Text] [Related]
29. Imaging pathological tau in atypical parkinsonian disorders. Coakeley S; Strafella AP Curr Opin Neurol; 2015 Aug; 28(4):447-52. PubMed ID: 26110795 [TBL] [Abstract][Full Text] [Related]
30. Glucocerebrosidase deficiency and mitochondrial impairment in experimental Parkinson disease. Noelker C; Lu L; Höllerhage M; Vulinovic F; Sturn A; Roscher R; Höglinger GU; Hirsch EC; Oertel WH; Alvarez-Fischer D; Andreas H J Neurol Sci; 2015 Sep; 356(1-2):129-36. PubMed ID: 26104567 [TBL] [Abstract][Full Text] [Related]
31. Skin biopsies in the differential diagnosis of parkinsonism: are we ready for simplified protocols? Doppler K; Volkmann J; Sommer C Brain; 2016 Jan; 139(Pt 1):e5. PubMed ID: 26351270 [No Abstract] [Full Text] [Related]